a U.S. manufacturer

National Resilience, commonly known as Resilience, is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company provides end-to-end manufacturing solutions across multiple modalities, including biologics, vaccines, nucleic acids, and cell and gene therapies. Resilience operates a network of high-tech facilities across North America, offering services from process development to commercial-scale production. The company is frequently cited as a key U.S.-based manufacturer supporting domestic supply chain resilience and biosecurity. Through strategic partnerships with biotechnology and pharmaceutical firms, Resilience accelerates the development and delivery of innovative treatments for cancer and infectious diseases.